Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Blaney

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trialN L Seibel, S M Blaney, M O'Brien, et al.
Cancer Research|September 15, 1995
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancerP C Adamson, F M Balis, J E Belasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitisL Bomgaars, J R Geyer, J Franklin, et al.
Cancer Research|December 15, 1990
Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primatesS M Blaney, F M Balis, L Hegedus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancerP C Adamson, G Reaman, J Z Finklestein, et al.
Neuropathology and Applied Neurobiology|January 24, 2007
Differential expression of survivin splice isoforms in medulloblastomasX-N Li, Q Shu, J M Su, et al.
The Journal of Infectious Diseases|January 1, 1992
Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected childrenF M Balis, P A Pizzo, K M Butler, et al.
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanineB J Kitchen, A Moser, E Lowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trialN L Seibel, S M Blaney, M O'Brien, et al.
Cancer Research|September 15, 1995
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancerP C Adamson, F M Balis, J E Belasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitisL Bomgaars, J R Geyer, J Franklin, et al.
Cancer Research|December 15, 1990
Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primatesS M Blaney, F M Balis, L Hegedus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancerP C Adamson, G Reaman, J Z Finklestein, et al.
Neuropathology and Applied Neurobiology|January 24, 2007
Differential expression of survivin splice isoforms in medulloblastomasX-N Li, Q Shu, J M Su, et al.
The Journal of Infectious Diseases|January 1, 1992
Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected childrenF M Balis, P A Pizzo, K M Butler, et al.
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanineB J Kitchen, A Moser, E Lowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.
Pageof 5